French expert consensus statement on diagnosis and management of primary hyperparathyroidism.
Vantyghem MC, Mirallié E, Al-Salameh A, Aubert S, Barraud S, Baud G, Ben Hamou A, Bertocchio JP, Borson-Chazot F, Bouillet B, Briet C, Buffet C, Caiazzo R, Cardot-Bauters C, Cariou B, Chabre O, Chanson P, Charbit J, Chéreau N, Chevalier B, Cirenei C, Coppin L, Corvillain B, Christou N, Cuny T, Deandreis D, Deguelte S, Delemer B, Desailloud R, Do Cao C, Donatini G, Drui D, Dupeux M, Espiard S, Figueres L, Frey S, Ghanassia E, Ghander C, Gaujoux S, Goichot B, Groussin L, Gueorguieva I, Guérin C, Hadoux J, Haissaguerre M, Henry H, Hindié E, Houiller P, Jannin A, Kerlan V, Klein M, Koumakis E, Kuczma P, Ladsous M, Lasolle H, Le Bras M, Lecoq AL, Lemaitre M, Lifante JC, Linglart A, Lopez AG, Lussey-Lepoutre C, Luton D, Maione L, Marciniak C, Mathonnet M, Menegaux F, Molin A, Mosbah H, Nominé-Criqui C, Odou MF, Osman D, Paladino NC, Picart C, Romanet P, Santucci N, Scheyer N, Sebag F, Sokol E, Taieb D, Tauveron I, Tresallet C, Triponez F, Vergès B, Vezzosi D, Brunaud L, Kamenicky P.
Vantyghem MC, et al. Among authors: groussin l.
Ann Endocrinol (Paris). 2025 Aug 30;86(5):102449. doi: 10.1016/j.ando.2025.102449. Online ahead of print.
Ann Endocrinol (Paris). 2025.
PMID: 40889554